Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab

Heppt MV, Goldscheider I, Tietze JK, Berking C (2017)

Publication Type: Journal article

Publication year: 2017

Journal

Cancer Immunology, Immunotherapy Springer Verlag (Germany)

Book Volume: 66

Pages Range: 1377-1378

Journal Issue: 10

DOI: 10.1007/s00262-017-2012-0

Involved external institutions

Klinikum der Universität München DE Germany (DE)

How to cite

APA:

Heppt, M.V., Goldscheider, I., Tietze, J.K., & Berking, C. (2017). Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab. Cancer Immunology, Immunotherapy, 66(10), 1377-1378. https://dx.doi.org/10.1007/s00262-017-2012-0

MLA:

Heppt, Markus V., et al. "Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab." Cancer Immunology, Immunotherapy 66.10 (2017): 1377-1378.

BibTeX: Download